Zobrazeno 1 - 2
of 2
pro vyhledávání: '"Christopher G Azzolli"'
Autor:
Valentina Nardi, Miguel Rivera, Hayley Robinson, Florian J. Fintelmann, Jennifer S. Temel, Zofia Piotrowska, Mari Mino-Kenudson, Subba R. Digumarthy, Inga T. Lennes, A. John Iafrate, Jessica J. Lin, Jochen K. Lennerz, Dora Dias-Santagata, Meghan J. Mooradian, Christopher G Azzolli, Julie M. Batten, Lecia V. Sequist, Justin F. Gainor, Ginger Y. Jiang, Jo-Anne O. Shepard, Alice T. Shaw, Long P. Le, Martha B. Pitman, Ibiayi Dagogo-Jack, Anna F. Farago, Vania Nosé, Rebecca S. Heist
Publikováno v:
JCO Precision Oncology. :1-13
Purpose Targeted therapy is the cornerstone of treatment of advanced EGFR-mutant non–small-cell lung cancer (NSCLC). Next-generation sequencing (NGS), the preferred method for genotyping, typically requires several weeks. Here, we assessed workflow
Autor:
Ibiayi, Dagogo-Jack, Christopher G, Azzolli, Florian, Fintelmann, Mari, Mino-Kenudson, Anna F, Farago, Justin F, Gainor, Ginger, Jiang, Zofia, Piotrowska, Rebecca S, Heist, Inga T, Lennes, Jennifer S, Temel, Meghan J, Mooradian, Jessica J, Lin, Subba R, Digumarthy, Julie M, Batten, Hayley, Robinson, Vania, Nose, Miguel, Rivera, Valentina, Nardi, Dora, Dias-Santagata, Long P, Le, Lecia V, Sequist, Martha, Pitman, Jo-Anne O, Shepard, Alice T, Shaw, A John, Iafrate, Jochen K, Lennerz
Publikováno v:
JCO precision oncology. 2018
Targeted therapy is the cornerstone of treatment of advancedWe performed rapid testing forBetween January 2015 and September 2017, we performed 243 rapidRapid genotyping facilitates earlier initiation of EGFR-directed therapies without compromising N